Article Listing - Vivus completes Ph II dosing of Alista

US APPROVAL OF QUIDEL'S CONCEIVE

13 April 1992

California-based Quidel Corp has announced that the US Food and Drug Administration has approved Conceive, its new one-step rapid immuno-diagnostic...

ISRAEL'S YISSUM R&D CO CLAIMS ACHIEVEMENTS

13 April 1992

Yissum is Israel's leading university R&D company, the Marketletter's local correspondent notes, and it offers more than 150 applied research...

FUJISAWA TAIWAN PLANT PLANNED

13 April 1992

Japan's Fujisawa Pharmaceutical says its 80%-owned Taiwan-based affiliate is to start construction of a new manufacturing plant at the company's...

FRENCH FOLINIC ACID STUDY

13 April 1992

A Parisian study has indicated that the levo chiral form of folinic acid has a potentiating effect on the efficacy...

EURO BULK DRUG MAKERS GROUP

13 April 1992

A committee has recently been set up, under the aegis of the European Chemical Industry Council (CEFIC), to represent European...

MODEST GROWTH FOR CIBA-GEIGY ITALIA

13 April 1992

Ciba-Geigy's Italian subsidiary achieved a modest increase for 1991 to 1,063 billion lire ($866.5 million), while profits climbed to 20...

HEPATITIS B VACCINE

13 April 1992

Researchers at the Hadassah Hospital in Jerusalem, Israel, have started clinical trials with a hepatitis B vaccine which is claimed...

APPOINTMENTS AT US HIMA

13 April 1992

The US Health Industry Manufacturers Association has elected Raymond Gilmartin as chairman of the board for 1992-3. Mr Gilmartin is...

BIOCHEM PHARMA STUDY

13 April 1992

Canada's BioChem Pharma Inc reports that it will launch a three-year study into potential treatments for heart attacks and strokes....

ORGANON LAUNCHES PHYSIOGINE IN FRANCE

13 April 1992

Organon has launched Physiogine (estriol), in 0.1% vaginal cream and 0.5mg capsule formulations for the local treatment of post-menopausal symptoms,...

Showing 94311-94320 of 95325 articles